Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

286.90
Delayed Data
As of 4:00pm ET
 -2.04 / -0.71%
Today’s Change
205.42
Today|||52-Week Range
307.33
+9.84%
Year-to-Date

Today’s Trading

Previous close288.94
Today’s open290.00
Day’s range286.22 - 289.91
Volume1,471,212
Average volume (3 months)1,782,518
Market cap$62.4B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.78%
Earnings growth (next 5 years)+8.72%
Revenue growth (last year)+9.37%
P/E ratio16.9
Price/Sales6.09
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.56-0.80%
ILMNIllumina Inc-1.22-0.75%
BIVVBioverativ Inc+0.75+1.58%
TECHBio-Techne Corp+0.17+0.16%
Data as of 4:15pm ET, 02/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$4.99
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs